Trial · NCT02024087
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events as a Measure of Safety and Tolerability. | Dalantercept 0.4 mg/kg Plus Sorafenib | 16 | Participants | ||
| Number of Participants With Adverse Events as a Measure of Safety and Tolerability. | Dalantercept 0.6 mg/kg Plus Sorafenib | 5 | Participants | ||
| Best Overall Response | Dalantercept 0.4 mg/kg Plus Sorafenib | Complete response | 0 | Participants | |
| Best Overall Response | Dalantercept 0.6 mg/kg Plus Sorafenib | Complete response | 0 | Participants | |
| Best Overall Response | Dalantercept 0.4 mg/kg Plus Sorafenib | Partial response | 0 | Participants | |
| Best Overall Response | Dalantercept 0.6 mg/kg Plus Sorafenib | Partial response | 0 | Participants | |
| Best Overall Response | Dalantercept 0.4 mg/kg Plus Sorafenib | Stable disease | 8 | Participants | |
| Best Overall Response | Dalantercept 0.6 mg/kg Plus Sorafenib | Stable disease | 2 | Participants | |
| Best Overall Response | Dalantercept 0.4 mg/kg Plus Sorafenib | Progressive disease | 7 | Participants | |
| Best Overall Response | Dalantercept 0.6 mg/kg Plus Sorafenib | Progressive disease | 1 | Participants | |
| Overall Survival (OS) | Dalantercept 0.4 mg/kg Plus Sorafenib | 7 | Participants | ||
| Overall Survival (OS) | Dalantercept 0.6 mg/kg Plus Sorafenib | 0 | Participants | ||
| Disease Control Rate (DCR) | Dalantercept 0.4 mg/kg Plus Sorafenib | 8 | Participants | ||
| Disease Control Rate (DCR) | Dalantercept 0.6 mg/kg Plus Sorafenib | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02024087/results